153 related articles for article (PubMed ID: 18281541)
1. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
[TBL] [Abstract][Full Text] [Related]
2. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer.
Gayther SA; Song H; Ramus SJ; Kjaer SK; Whittemore AS; Quaye L; Tyrer J; Shadforth D; Hogdall E; Hogdall C; Blaeker J; DiCioccio R; McGuire V; Webb PM; Beesley J; Green AC; Whiteman DC; ; Goodman MT; Lurie G; Carney ME; Modugno F; Ness RB; Edwards RP; Moysich KB; Goode EL; Couch FJ; Cunningham JM; Sellers TA; Wu AH; Pike MC; Iversen ES; Marks JR; Garcia-Closas M; Brinton L; Lissowska J; Peplonska B; Easton DF; Jacobs I; Ponder BA; Schildkraut J; Pearce CL; Chenevix-Trench G; Berchuck A; Pharoah PD;
Cancer Res; 2007 Apr; 67(7):3027-35. PubMed ID: 17409409
[TBL] [Abstract][Full Text] [Related]
3. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort.
Azzato EM; Driver KE; Lesueur F; Shah M; Greenberg D; Easton DF; Teschendorff AE; Caldas C; Caporaso NE; Pharoah PD
Breast Cancer Res; 2008; 10(3):R47. PubMed ID: 18507837
[TBL] [Abstract][Full Text] [Related]
4. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
Goode EL; Fridley BL; Vierkant RA; Cunningham JM; Phelan CM; Anderson S; Rider DN; White KL; Pankratz VS; Song H; Hogdall E; Kjaer SK; Whittemore AS; DiCioccio R; Ramus SJ; Gayther SA; Schildkraut JM; Pharaoh PP; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):935-44. PubMed ID: 19258477
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.
Mann A; Hogdall E; Ramus SJ; DiCioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Ponder BA; Kjaer SK; Gayther SA; Thompson DJ; Pharoah PD; Song H
Eur J Cancer; 2008 Oct; 44(15):2259-65. PubMed ID: 18723338
[TBL] [Abstract][Full Text] [Related]
6. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
Driver KE; Song H; Lesueur F; Ahmed S; Barbosa-Morais NL; Tyrer JP; Ponder BA; Easton DF; Pharoah PD; Dunning AM;
Carcinogenesis; 2008 Feb; 29(2):333-41. PubMed ID: 18174243
[TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women.
Cai H; Xiang YB; Qu S; Long J; Cai Q; Gao J; Zheng W; Shu XO
Am J Epidemiol; 2011 Jun; 173(11):1263-71. PubMed ID: 21454826
[TBL] [Abstract][Full Text] [Related]
8. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population.
Ma H; Chen J; Pan S; Dai J; Jin G; Hu Z; Shen H; Shu Y
Lung Cancer; 2011 Jul; 73(1):32-7. PubMed ID: 21145615
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in
Si W; Kang S; Sun H; Chen J; Cao S; Li Y
Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
[TBL] [Abstract][Full Text] [Related]
10. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival.
Quaye L; Dafou D; Ramus SJ; Song H; Gentry-Maharaj A; Notaridou M; Hogdall E; Kjaer SK; Christensen L; Hogdall C; Easton DF; Jacobs I; Menon U; Pharoah PD; Gayther SA
Hum Mol Genet; 2009 May; 18(10):1869-78. PubMed ID: 19270026
[TBL] [Abstract][Full Text] [Related]
11. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.
Barbieri RB; Bufalo NE; Secolin R; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
Eur J Endocrinol; 2014 Dec; 171(6):761-7. PubMed ID: 25565272
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.
Sun Y; Tao W; Huang M; Wu X; Gu J
J Cell Mol Med; 2017 Mar; 21(3):510-518. PubMed ID: 28233473
[TBL] [Abstract][Full Text] [Related]
14. Common variants in RB1 gene and risk of invasive ovarian cancer.
Song H; Ramus SJ; Shadforth D; Quaye L; Kjaer SK; Dicioccio RA; Dunning AM; Hogdall E; Hogdall C; Whittemore AS; McGuire V; Lesueur F; Easton DF; Jacobs IJ; Ponder BA; Gayther SA; Pharoah PD
Cancer Res; 2006 Oct; 66(20):10220-6. PubMed ID: 17047088
[TBL] [Abstract][Full Text] [Related]
15. Inherited determinants of ovarian cancer survival.
Goode EL; Maurer MJ; Sellers TA; Phelan CM; Kalli KR; Fridley BL; Vierkant RA; Armasu SM; White KL; Keeney GL; Cliby WA; Rider DN; Kelemen LE; Jones MB; Peethambaram PP; Lancaster JM; Olson JE; Schildkraut JM; Cunningham JM; Hartmann LC
Clin Cancer Res; 2010 Feb; 16(3):995-1007. PubMed ID: 20103664
[TBL] [Abstract][Full Text] [Related]
16. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P
J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
[TBL] [Abstract][Full Text] [Related]
18. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome.
Charbonneau B; Moysich KB; Kalli KR; Oberg AL; Vierkant RA; Fogarty ZC; Block MS; Maurer MJ; Goergen KM; Fridley BL; Cunningham JM; Rider DN; Preston C; Hartmann LC; Lawrenson K; Wang C; Tyrer J; Song H; deFazio A; Johnatty SE; Doherty JA; Phelan CM; Sellers TA; Ramirez SM; Vitonis AF; Terry KL; Van Den Berg D; Pike MC; Wu AH; Berchuck A; Gentry-Maharaj A; Ramus SJ; Diergaarde B; Shen H; Jensen A; Menkiszak J; Cybulski C; Lubiłski J; Ziogas A; Rothstein JH; McGuire V; Sieh W; Lester J; Walsh C; Vergote I; Lambrechts S; Despierre E; Garcia-Closas M; Yang H; Brinton LA; Spiewankiewicz B; Rzepecka IK; Dansonka-Mieszkowska A; Seibold P; Rudolph A; Paddock LE; Orlow I; Lundvall L; Olson SH; Hogdall CK; Schwaab I; du Bois A; Harter P; Flanagan JM; Brown R; Paul J; Ekici AB; Beckmann MW; Hein A; Eccles D; Lurie G; Hays LE; Bean YT; Pejovic T; Goodman MT; Campbell I; Fasching PA; Konecny G; Kaye SB; Heitz F; Hogdall E; Bandera EV; Chang-Claude J; Kupryjanczyk J; Wentzensen N; Lambrechts D; Karlan BY; Whittemore AS; Culver HA; Gronwald J; Levine DA; Kjaer SK; Menon U; Schildkraut JM; Pearce CL; Cramer DW; Rossing MA; Chenevix-Trench G; ; ; Pharoah PD; Gayther SA; Ness RB; Odunsi K; Sucheston LE; Knutson KL; Goode EL
Cancer Immunol Res; 2014 Apr; 2(4):332-40. PubMed ID: 24764580
[TBL] [Abstract][Full Text] [Related]
19. Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics.
Helsten T; Kato S; Schwaederle M; Tomson BN; Buys TP; Elkin SK; Carter JL; Kurzrock R
Mol Cancer Ther; 2016 Jul; 15(7):1682-90. PubMed ID: 27196769
[TBL] [Abstract][Full Text] [Related]
20. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility.
Murali A; Nalinakumari KR; Thomas S; Kannan S
Br J Oral Maxillofac Surg; 2014 Sep; 52(7):652-8. PubMed ID: 24947332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]